Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Language
Publication year range
1.
Yearb Med Inform ; 26(1): 28-37, 2017 Aug.
Article in English | MEDLINE | ID: mdl-28480474

ABSTRACT

Objectives: To identify common methodological challenges and review relevant initiatives related to the re-use of patient data collected in routine clinical care, as well as to analyze the economic benefits derived from the secondary use of this data. Through the use of several examples, this article aims to provide a glimpse into the different areas of application, namely clinical research, genomic research, study of environmental factors, and population and health services research. This paper describes some of the informatics methods and Big Data resources developed in this context, such as electronic phenotyping, clinical research networks, biorepositories, screening data banks, and wide association studies. Lastly, some of the potential limitations of these approaches are discussed, focusing on confounding factors and data quality. Methods: A series of literature searches in main bibliographic databases have been conducted in order to assess the extent to which existing patient data has been repurposed for research. This contribution from the IMIA working group on "Data mining and Big Data analytics" focuses on the literature published during the last two years, covering the timeframe since the working group's last survey. Results and Conclusions: Although most of the examples of secondary use of patient data lie in the arena of clinical and health services research, we have started to witness other important applications, particularly in the area of genomic research and the study of health effects of environmental factors. Further research is needed to characterize the economic impact of secondary use across the broad spectrum of translational research.


Subject(s)
Data Mining , Patient Care , Biomedical Research , Databases, Factual , Humans , Translational Research, Biomedical
2.
J Fish Dis ; 40(10): 1285-1297, 2017 Oct.
Article in English | MEDLINE | ID: mdl-28093775

ABSTRACT

Lactococcus garvieae is the aetiological agent of lactococcosis, a haemorrhagic septicaemia that affects marine and freshwater fish, with special incidence and economic relevance in farmed rainbow trout. Water temperature is one of the most important predisposing factors in the development of lactococcosis outbreaks. Lactococcosis in trout usually occur when water temperatures rise to about 18 °C, while fish carriers remain asymptomatic at temperatures below 13 °C. The aim of this work was to analyse the differences in the complete transcriptome response of L. garvieae grown at 18 °C and at 13 °C and to identify the immunogenic proteins expressed by this bacterium at 18 °C. Our results show that water temperature influences the expression of L. garvieae genes involved in the lysis of part of the bacterial cell population and in the cold response bacterial adaptation. Moreover, the surface immunogenic protein profile at 18 °C suggests an important role of the lysozyme-like enzyme, WxL surface proteins and some putative moonlighting proteins (proteins with more than one function, usually associated with different cellular locations) as virulence factors in L. garvieae. The results of this study could provide insights into the understanding of the virulence mechanisms of L. garvieae in fish.


Subject(s)
Bacterial Proteins/genetics , Fish Diseases/microbiology , Gram-Positive Bacterial Infections/veterinary , Lactococcus/physiology , Oncorhynchus mykiss , Animals , Bacterial Proteins/metabolism , Fish Diseases/genetics , Fish Diseases/immunology , Gram-Positive Bacterial Infections/genetics , Gram-Positive Bacterial Infections/immunology , Gram-Positive Bacterial Infections/microbiology , Protein Array Analysis/veterinary , Proteome , Temperature , Transcriptome
3.
Methods Inf Med ; 45(2): 158-62, 2006.
Article in English | MEDLINE | ID: mdl-16538281

ABSTRACT

OBJECTIVES: To develop a tool for then easy and user-friendly management of peptide microarray experiments and for the use of the results of these experiments for the study the immune response against HIV virus infection in clinical samples. METHODS: Applying bioinformatics and statistics for the analysis of data coming from microarray experiments as well as implementing a MIAME (Minimum Information About a Microarray Experiment) compliant database for managing and annotating experiments, results and samples. RESULTS: We present a new tool for managing not only nucleic acid microarray experiments but also protein microarray experiments. From the analysis of experimental data, we can detect different profiles in the reactivity of the sera with different genotypes. CONCLUSIONS: We have developed a new tool for managing microarray data including clinical annotations for the samples as well as the capability of annotating other microarray formats different to those based on nucleic acids. The use of peptide microarrays and bioinformatics analysis opens a new scope for the characterization of the immune response, and analyzing and identifying the humoral response of viruses with different genotypes.


Subject(s)
HIV Seropositivity/genetics , Oligonucleotide Array Sequence Analysis , Peptides/genetics , Viral Proteins/genetics , Computational Biology , HIV Antibodies/biosynthesis , HIV Seropositivity/immunology , Humans , Oligonucleotide Array Sequence Analysis/statistics & numerical data , Protein Array Analysis , Serotyping , Spain , Statistics as Topic , Viral Proteins/chemistry
SELECTION OF CITATIONS
SEARCH DETAIL
...